
GC64518
Ziftomenib
Also known as 4-methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]-1-[(2S)-2-(4-methylsulfonylpiperazin-1-yl)propyl]indole-2-carbonitrile
Ziftomenib is a highly selective and orally active inhibitor of the Menin-MLL (mixed lineage leukemia) interaction used to treat relapsed or refractory acute myeloid leukemia (AML)
ChemicalCAS2134675-36-6MW717.87FormulaC33H42F3N9O2S2
- CAS number
- 2134675-36-6
- Molecular weight
- 717.87
- Formula
- C33H42F3N9O2S2
- InChIKey
- BGGALFIXXQOTPY-NRFANRHFSA-N
- Catalogue number
- GC64518
- Brand
- GLPBIO
Computed properties PubChem CID 138497449 · XLogP 5.6 · TPSA 159 Ų · H-bond donors 2
- XLogP
- 5.6
- TPSA
- 159 Ų
- H-bond donors
- 2
- H-bond acceptors
- 14
- Rotatable bonds
- 10
- Heavy atoms
- 49
SMILES CC1=C(C=CC2=C1C=C(N2C[C@H](C)N3CCN(CC3)S(=O)(=O)C)C#N)CN4CCC(CC4)NC5=C6C=C(SC6=NC(=N5)NC)CC(F)(F)F
Computed descriptors from PubChem (CID 138497449), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il